Noxopharm Limited
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants (NCT07072611) | Noxopharm Limited | 2025-07-14 |
| A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma (NCT05100628) | Noxopharm Limited | 2022-02-11 |
| A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors (NCT04957290) | Noxopharm Limited | 2021-10-25 |
| A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 (NCT04555213) | Noxopharm Limited | 2020-09-30 |
| A Study of Safety and Tolerability of NOX66 in Healthy Volunteers (NCT03780465) | Noxopharm Limited | 2019-03-01 |
| Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer (NCT03307629) | Noxopharm Limited | 2017-11-01 |
Track Noxopharm Limited automatically
Every clearance here is in the API, with alerts when new ones post.